Rash News and Research

RSS

Study suggests a single dose of JYNNEOS vaccine may lessen the severity of mpox illness

Researchers pursued evidence that the JYNNEOS vaccine offered some protection against the mpox disease, especially they confirmed the duration for which the one dose of this vaccine conferred protection.

3 Jan 2023

Underlying genetic cause for MIS-C complications after COVID-19 identified

A recent Science journal study determined the underlying cause of MIS-C related to SARS-CoV-2 in some children. It hypothesized that monogenic inborn errors of immunity (IEI) is the primary reason for this condition. Identifying these inborn errors is expected to help elucidate the disease's cellular, molecular, and immunological basis.

2 Jan 2023

NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma

A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS).

28 Dec 2022

An Air Force career held up because of debt owed for medical bills

In late August 2022, Samaria Bradford was prepared to leave for basic training any day. She'd been in contact with an Air Force recruiter.

21 Dec 2022

Single-dose smallpox vaccine could be effective against mpox

Researchers estimated the efficacy of a single-dose Modified Vaccinia Ankara-Bavaria Nordic (MVA-BN) vaccine against mpox (MPX) in gay, bisexual, and other men who have sex with men (GBMSM).

19 Dec 2022

The mpox viral load kinetics over time in various parts of the body

Researchers characterized the time to mpox virus clearance of immunocompetent individuals with mild MPX in a real-world community-based setting utilizing longitudinal information.

16 Dec 2022

How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

Researchers compared ecological niches to identify probable mpox virus reservoir hosts.

15 Dec 2022

Knowledge and attitudes to mpox among GBMSM in Australia

Researchers presented the results of a cross-sectional survey done in Australia between August and September 2022.

12 Dec 2022

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

12 Dec 2022

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.

12 Dec 2022

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.

9 Dec 2022

Addition of capivasertib to fulvestrant doubles progression-free survival in HR-positive breast cancer patients

In patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of the investigational AKT inhibitor capivasertib to fulvestrant (Faslodex) doubled the median progression-free survival compared with placebo plus fulvestrant in the phase III CAPItello-291 clinical trial, according to results presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

9 Dec 2022

Study shows only 75.8% of children under 15 have antibodies against measles

A study conducted in Brazil and reported in an article in Vaccines shows that in the São José do Rio Preto region in the northwest of São Paulo state, only 75.8% of children aged 0-15 have antibodies against measles.

1 Dec 2022

New evidence of mpox virus transmission before onset of symptoms

Researchers extensively followed-up high-risk contacts of clade IIb mpox (MPX) virus (MPXV)-infected patients to evaluate the risk of MPX after MPXV exposure and to characterize early MPXV infections.

30 Nov 2022

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

Small UK study investigates the effectiveness of a single MVA-BN dose against mpox disease

Researchers estimated the single-dose MVA-BN vaccine effectiveness against symptomatic mpox among high-risk gay, bisexual and other men who have sex with men in England.

29 Nov 2022

Study shows no undetected monkeypox virus transmission before May 2022 in Rotterdam and Amsterdam

Researchers investigated whether undetected human monkeypox virus transmission occurred before Rotterdam and Amsterdam's first documented monkeypox cases.

23 Nov 2022

Shingles linked with higher long-term risk of major cardiovascular event

A new study by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, demonstrated that shingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of a major cardiovascular event such a stroke or heart attack.

22 Nov 2022

Remdesivir appears to make a big difference in Japanese patients with COVID-19

The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial.

22 Nov 2022

World Antimicrobial Awareness Week 2022: The problem of antimicrobial resistance in combating sepsis

As part of World Antimicrobial Resistance Week 2022, News-Medical speaks to Dr. Catharina Hartman, a trustee of the charity Sepsis Research FEAT, about the problems associated with combating sepsis brought on by antimicrobial resistance.

20 Nov 2022

Rash News and Research

Study suggests a single dose of JYNNEOS vaccine may lessen the severity of mpox illness

Underlying genetic cause for MIS-C complications after COVID-19 identified

NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma

An Air Force career held up because of debt owed for medical bills

Single-dose smallpox vaccine could be effective against mpox

The mpox viral load kinetics over time in various parts of the body

How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

Knowledge and attitudes to mpox among GBMSM in Australia

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Addition of capivasertib to fulvestrant doubles progression-free survival in HR-positive breast cancer patients

Study shows only 75.8% of children under 15 have antibodies against measles

New evidence of mpox virus transmission before onset of symptoms

Monkeypox renamed "mpox" in an effort to combat stigma

Small UK study investigates the effectiveness of a single MVA-BN dose against mpox disease

Study shows no undetected monkeypox virus transmission before May 2022 in Rotterdam and Amsterdam

Shingles linked with higher long-term risk of major cardiovascular event

Remdesivir appears to make a big difference in Japanese patients with COVID-19

World Antimicrobial Awareness Week 2022: The problem of antimicrobial resistance in combating sepsis

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News